Tag: Human Trial

ebola
Experimental Ebola vaccines found safe, effective in human trial

New York: Two experimental vaccines against the Ebola virus have demonstrated both safety and the ability to elicit an immune response that would last for at least one year, results of a clinical trial have shown. The findings showed that responses to both vaccine candidates — cAd3-EBOZ and rVSV-ZEBOV — were modest at one week. However, by […]

  • Tuesday, 06 July 2021
Human trial to assess efficacy of autism drug treatment

New York: A clinical trial to investigate the safety and efficacy of a drug therapy for autism has been launched in the US, University of California, San Diego School of Medicine has said in a statement. The phase 1 clinical trial, which is recruiting 20 participants, will evaluate suramin a century-old drug still used for […]

  • Tuesday, 22 June 2021
coronavaccine
Oxford Varsity COVID-19 Vaccine Human Trials From Thursday: UK Health Secretary

London: The UK government on Tuesday announced that the human trial of a potential COVID-19 candidate vaccine being developed by researchers at the University of Oxford will begin from Thursday. Scientists at the University of Oxford last week promised a super-fast vaccine during a virtual press conference, saying the vaccine will be available by September. […]

  • Saturday, 17 April 2021
COVID-19-vaccine
COVID-19 Treatment: Moderna's Coronavirus Vaccine Shows Early Promise In Human Trial, Stock Soars

New York: In a ray of hope against Covid-19, an mRNA vaccine under human clinical trial by Massachusetts-bases biotechnology giant Moderna has shown promising results by generating an immune-system response in the body to fight coronavirus. mRNA-1273 is an mRNA vaccine against SARS-CoV-2 which was selected by Moderna in collaboration with investigators from the Vaccine […]

  • Friday, 16 April 2021
COVID-19-vaccine
Johnson & Johnson To Begin Human Trial Of Covid Vaccine In July

New York: Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen). The trial for the vaccine, Ad26.COV2-S, recombinant, was initially scheduled to begin in September. “Based on the strength of the preclinical […]

  • Friday, 16 April 2021
scrollToTop